596 filings
Page 9 of 30
8-K
96dxg2l3kcvztm
1 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
qq9u4w505
31 Aug 16
Elite Announces Development and License Agreement with SunGen Pharma LLC
12:00am
424B3
yw3wm1cb1d1 hxuhzgt
9 Aug 16
Prospectus supplement
12:00am
8-K
xz4q54cpf2ij1cx4f9xa
9 Aug 16
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information
12:00am
424B3
48q fsddicazjrxsbz
21 Jul 16
Prospectus supplement
12:00am
8-K
3qv g6d5n
21 Jul 16
Regulation FD Disclosure
12:00am
424B3
nil7t0
15 Jul 16
Prospectus supplement
12:00am
8-K
uog esgufrt
15 Jul 16
FDA Issues Complete Response Letter for SequestOxâ„¢ New Drug Application
12:00am
424B3
vx7d7485v54 zuhc
14 Jul 16
Prospectus supplement
12:00am
EFFECT
rg031tapzexm eo
13 Jul 16
Notice of effectiveness
12:00am
CT ORDER
4eu05ko
11 Jul 16
Confidential treatment order
12:00am
CORRESP
81g4 nwv0z
11 Jul 16
Correspondence with SEC
12:00am
UPLOAD
cckv0b2pqhzh8q3g
6 Jul 16
Letter from SEC
12:00am
NT 10-K
t9e g2dyfl502
15 Jun 16
Notice of late annual filing
12:00am
8-K
l1bwppd
15 Jun 16
Results of Operations and Financial Condition
12:00am
8-K
nao3sv
4 May 16
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
12:00am